Study Start Up (SSU) is one of the most critical steps in the clinical trial process as it kicks off the process for a new product’s clinical trial. Effective study start up depends on speed, efficient processes, and complete accuracy. Delays ultimately impact a product’s approval and launch, raising the cost of a clinical trial and potentially delaying life-altering, or even life-saving, medicines to patients.
SSU managers must effectively coordinate complex process flows, multiple stakeholders, and every detail within study start up, while giving careful consideration to the safety of patients. A solution is required to enable processes to run efficiently while assuring regulations are being met.
Read more to learn how life sciences organizations can maintain accuracy, transparency, and speed, while meeting the needs of the hospitals, clinics, research facilities, and individuals involved in the process?
No comments:
Post a Comment